Economic evaluation of the OSAC randomised controlled trial: oral corticosteroids for non-asthmatic adults with acute lower respiratory tract infection in primary care. [electronic resource]
Producer: 20210216Description: e033567 p. digitalISSN:- 2044-6055
- Acute Disease
- Administration, Oral
- Adrenal Cortex Hormones -- economics
- Adult
- Anti-Inflammatory Agents -- economics
- Asthma
- Cost Savings
- Cost-Benefit Analysis
- Cough
- Drug Costs
- Drug Prescriptions -- economics
- England
- Female
- General Practice
- Humans
- Male
- Middle Aged
- Prednisolone -- economics
- Primary Health Care -- economics
- Quality of Life
- Quality-Adjusted Life Years
- Respiratory Tract Infections -- complications
- Severity of Illness Index
- State Medicine
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.